OctreotideHormone TherapySafety Rating 8/10
Primary research areaAcromegaly
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range100-600 mcg/day SC; 10-30 mg monthly (LAR)
AdministrationSubcutaneous injection or IM depot
Safety8/10 · FDA-approved (Sandostatin)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Octreotide
Mechanism of action
Somatostatin receptor agonist (SSTR2/5); inhibits GH, IGF-1, insulin, glucagon secretion
Safety profile
GI disturbances, cholelithiasis, bradycardia, hyperglycemia · Decades of use; gallstones, GI side effects, glucose changes manageable; well-characterized
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Octreotide below your target.
Related pages